MOST cases of tuberculosis
remain undiagnosed since the
standard testing procedure is not
effective in children, according to
Dr Marais, a paediatrician based at
the Children’s Hospital at
Westmead.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 27 Jul 12 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jul 12
CONSUMERS and health professionals are advised that Biogen Australia, in consultation with the Therapeutic Goods Administration (TGA), will withdraw multiple sclerosis therapy Zinbryta (daclizumab) from the Australian market following a review of cases of serious inflammatory brain disorders in Europe (PD 05 Mar).